ArticleArthritis research & therapy2022

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

M Elaine Husni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.